Augmentation strategies for treatment-resistant depression: a literature review
Carvalho AF, Cavalcante JL, Castelo MS, Lima MC.
Department of Medicine, Psychiatry Outpatient Clinics,
Federal University of Ceará, Fortaleza, CE, Brazil.
J Clin Pharm Ther. 2007 Oct;32(5):415-28.
ABSTRACTBackground: The large majority of depressed patients fail to remit on the first antidepressant prescribed. These patients with residual symptoms have higher relapse rates and poorer outcomes than those who remit. Treatment-resistant depression (TRD) is a therapeutic challenge for the clinician. Augmentation pharmacotherapy refers to the addition of drugs that are not standard antidepressants in order to enhance the effect of a classical antidepressant drug. The aim of this paper was to review the available evidence on the various augmenting agents that have been tested for efficacy in TRD. Methods: Electronic databases and relevant textbooks were searched and the information retrieved was integrated in this review. Results: Although augmentation strategies have been tested with various pharmacological agents, there are few controlled studies published. Lithium, triiodothyronine (T3), buspirone and pindolol have been most widely studied. Other agents include dopaminergic agents, atypical antipsychotics, psychostimulants, benzodiazepines/hypnotics, hormones and anticonvulsants. Conclusion: The augmentation therapy with the best evidence was the lithium-antidepressant combination, especially in patients not responding to tricyclic agents. However, good results have also been reported with augmentation strategies involving T3 and buspirone.TCAs
T3 v T4
Lithium and depression
Antidepressants: how fast?
The thyroid axis and depression
Long-term side effects of antidepressants
Pharmacogenomics and new antidepressants
and further reading
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World
The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family